lanflox 100 mg/ml solution for use in drinking water for chickens and turkeys
vetpharma animal health, s.l. - enrofloxacin - solution for use in drinking water - 100 milligram(s)/millilitre - enrofloxacin - chickens, turkeys - antibacterial
lanflox 100 mg/ml solution for use in drinking water for chickens and turkeys
vetpharma animal health, s.l - enrofloxacin - solution for use in drinking water - antimicrobial - chickens, turkeys
lanflox 100 mg/ml solution for use in drinking water for chickens and turkeys
vetpharma animal health, s.l. - enrofloxacin - infus/pdr/oral soln - 100 mg/ml - enrofloxacin - fowl - chicken, fowl - turkey - antibacterial
lanflox 100 mgml veterinary
romat ltd - enrofloxacin - solution (oral) - enrofloxacin 100 mg / 1 ml - treatment of infections caused by the following bacteria susceptible to enrofloxacin:chickensmycoplasma gallisepticum, mycoplasma synoviae,avibacterium paragallinarum, pasteurella multocida.turkeymycoplasma gallisepticum, mycoplasma synoviae, pasteurella multocida.enrofloxacin should be used only after sensitivity of the bacteria has been confirmed and there is no alternative therapy (due to resistance to other antibiotics).
lanflox 100 mg/ml ενέσιμο διάλυμα για βοοειδή και χοίρους
unisol 5 mg/ml oral solution for piglets
vetpharma animal health, s.l. - enrofloxacin - oral solution - 5 milligram(s)/millilitre - enrofloxacin - pigs - antibacterial
unisol 0.5% w/v oral solution for piglets
universal farma, s.l - enrofloxacin -
unisol 2.5% w/v oral solution for calves
universal farma, s.l - enrofloxacin -
unisol 25 mg/ml oral solution for calves
vetpharma animal health, s.l. - enrofloxacin - oral solution - 25 milligram(s)/millilitre - enrofloxacin - cattle - antibacterial
baxdela- delafloxacin meglumine tablet baxdela- delafloxacin meglumine injection, powder, lyophilized, for solution
melinta therapeutics, llc - delafloxacin meglumine (unii: n7v53u4u4t) (delafloxacin - unii:6315412yvf) - delafloxacin 450 mg - baxdela is indicated in adults for the treatment of acute bacterial skin and skin structure infections (absssi) caused by the following susceptible microorganisms: staphylococcus aureus (including methicillin-resistant [mrsa] and methicillin-susceptible [mssa] isolates), staphylococcus haemolyticus, staphylococcus lugdunensis, streptococcus agalactiae , streptococcus anginosus group (including streptococcus anginosus , streptococcus intermedius , and streptococcus constellatus ), streptococcus pyogenes , enterococcus faecalis , escherichia coli, enterobacter cloacae, klebsiella pneumoniae, and pseudomonas aeruginosa. baxdela is indicated in adults for the treatment of community-acquired bacterial pneumonia (cabp) caused by the following susceptible microorganisms: streptococcus pneumoniae, staphylococcus aureus (methicillin-susceptible [mssa] isolates only), klebsiella pneumoniae , escherichia coli, pseudomonas aeruginosa, haemophilus influenzae, haemophilus parainfluenzae , chlamydia pneumoniae , legione